Related Experiment Video

Updated: Jun 21, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
12:06

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation

Stanley K L Ng1, Soek-Ying Neo, Yann-Wan Yap

  • 1Singapore Immunology Network A *STAR, Singapore.

Biochemical and Biophysical Research Communications
|July 14, 2009
PubMed

Insights

This study reveals that class II PI3K alpha (PIK3C2alpha) significantly impairs hepatocellular carcinoma (HCC) cell growth. Targeting PIK3C2alpha shows potential for HCC treatment by inhibiting cell proliferation and inducing apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) involves complex signaling pathway disruptions, including the phosphoinositide-3-kinase (PI3K/AKT) pathway.
  • The role of specific PI3K catalytic isoforms, especially class II, in HCC proliferation remains underexplored.

Purpose of the Study:

  • To investigate the function of PI3K catalytic isoforms, with a focus on class II isoforms, in regulating HCC cell proliferation.
  • To determine if PIK3C2alpha plays a role in HCC growth and survival.

Main Methods:

  • Utilized small interfering RNAs (siRNAs) to specifically ablate eight known catalytic PI3K isoforms in HCC cells.
  • Assessed the impact of PIK3C2alpha ablation on cell growth, colony formation, and apoptosis markers (caspase 3).
  • Analyzed PIK3C2alpha mRNA and protein levels, and examined gene dosage and expression in tumor versus non-tumor HCC tissues from 19 patients.

Main Results:

  • Specific ablation of class II PI3K alpha (PIK3C2alpha) was most effective in impairing HCC cell growth.
  • PIK3C2alpha deficiency led to reduced colony formation and growth arrest, associated with increased caspase 3 levels.
  • A significant difference in PIK3C2alpha gene dosage and expression was observed between HCC tumor and non-tumor tissues.

Conclusions:

  • Class II PIK3C2alpha, in addition to class I PI3Ks, can modulate hepatocellular carcinoma cell growth.
  • PIK3C2alpha represents a potential therapeutic target for HCC treatment.
  • This study provides novel insights into the role of PI3K class II isoforms in cancer biology.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...